89 related articles for article (PubMed ID: 26779931)
1. Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts.
Dabas R; Lee R; Servito MT; Dharmani-Khan P; Modi M; van Slyke T; Luider J; Durand C; Larratt L; Brandwein J; Morris D; Daly A; Khan FM; Storek J
Biol Blood Marrow Transplant; 2016 May; 22(5):815-24. PubMed ID: 26779931
[TBL] [Abstract][Full Text] [Related]
2. More acute lymphoid leukemia than acute myeloid leukemia blasts are killed by rabbit antithymocyte globulin.
Dabas R; Khan PD; Modi M; Khan FM; Storek J
Cytotherapy; 2019 Nov; 21(11):1161-1165. PubMed ID: 31543396
[TBL] [Abstract][Full Text] [Related]
3. Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells.
Dabas R; Dharmani-Khan P; Modi M; Van Slyke T; Luider J; Morris D; Brandwein J; Daly A; Khan FM; Storek J
Bone Marrow Transplant; 2019 Apr; 54(4):549-559. PubMed ID: 30108326
[TBL] [Abstract][Full Text] [Related]
4. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Finke J; Bethge WA; Schmoor C; Ottinger HD; Stelljes M; Zander AR; Volin L; Ruutu T; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Kolb HJ; Bertz H; Egger M; Grishina O; Socié G;
Lancet Oncol; 2009 Sep; 10(9):855-64. PubMed ID: 19695955
[TBL] [Abstract][Full Text] [Related]
5. Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation.
Storek J; Mohty M; Boelens JJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):959-70. PubMed ID: 25482864
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal rabbit antithymocyte globulin induces apoptosis and has cytotoxic effects on human leukemic cells.
Liu H; Qin Y; Wang X; Xie K; Yang Y; Zhu J; Zhao C; Wang C
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):345-54. PubMed ID: 22677206
[TBL] [Abstract][Full Text] [Related]
7. High rabbit-antihuman thymocyte globulin levels are associated with low likelihood of graft-vs-host disease and high likelihood of posttransplant lymphoproliferative disorder.
Podgorny PJ; Ugarte-Torres A; Liu Y; Williamson TS; Russell JA; Storek J
Biol Blood Marrow Transplant; 2010 Jul; 16(7):915-26. PubMed ID: 20226870
[TBL] [Abstract][Full Text] [Related]
8. Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.
Duléry R; Mohty M; Duhamel A; Robin M; Beguin Y; Michallet M; Vigouroux S; Lioure B; Garnier A; El Cheikh J; Bulabois CE; Huynh A; Bay JO; Daguindau E; Ceballos P; Clément L; Dauriac C; Maillard N; Legrand F; Cornillon J; Guillerm G; François S; Lapusan S; Chevallier P; Damaj G; Yakoub-Agha I
Biol Blood Marrow Transplant; 2014 May; 20(5):646-54. PubMed ID: 24462982
[TBL] [Abstract][Full Text] [Related]
9. Rabbit anti T-lymphocyte globulin induces apoptosis in peripheral blood mononuclear cell compartments and leukemia cells, while hematopoetic stem cells are apoptosis resistant.
Grüllich C; Ziegler C; Finke J
Biol Blood Marrow Transplant; 2009 Feb; 15(2):173-82. PubMed ID: 19167677
[TBL] [Abstract][Full Text] [Related]
10. Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.
Mohty M; Labopin M; Balère ML; Socié G; Milpied N; Tabrizi R; Ifrah N; Hicheri Y; Dhedin N; Michallet M; Buzyn A; Cahn JY; Bourhis JH; Blaise D; Raffoux C; Espérou H; Yakoub-Agha I
Leukemia; 2010 Nov; 24(11):1867-74. PubMed ID: 20882046
[TBL] [Abstract][Full Text] [Related]
11. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
Russell JA; Turner AR; Larratt L; Chaudhry A; Morris D; Brown C; Quinlan D; Stewart D
Biol Blood Marrow Transplant; 2007 Mar; 13(3):299-306. PubMed ID: 17317583
[TBL] [Abstract][Full Text] [Related]
12. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation.
Nachbaur D; Eibl B; Kropshofer G; Meister B; Mitterschiffthaler A; Schennach H; Fischer G; Kopp M; Gunsilius E; Gastl G
J Hematother Stem Cell Res; 2002 Aug; 11(4):731-7. PubMed ID: 12201962
[TBL] [Abstract][Full Text] [Related]
13. High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic, but not acute, graft-versus-host disease.
Chawla S; Dharmani-Khan P; Liu Y; Prokopishyn N; Amlish Munir M; Griffiths C; Khan FM; Stewart DA; Russell JA; Daly A; Storek J
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1156-62. PubMed ID: 24727330
[TBL] [Abstract][Full Text] [Related]
14. Transient grades 3 to 4 acute hepatitis is a common complication of rabbit antithymocyte globulin (thymoglobulin) administered before allogeneic stem cell transplantation.
Médiavilla C; Vigouroux S; Tabrizi R; Pigneux A; Duclos C; Mohr C; Robles M; Milpied N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):661-5. PubMed ID: 25536216
[TBL] [Abstract][Full Text] [Related]
15. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group.
Basara N; Baurmann H; Kolbe K; Yaman A; Labopin M; Burchardt A; Huber C; Fauser AA; Schwerdtfeger R
Bone Marrow Transplant; 2005 May; 35(10):1011-8. PubMed ID: 15821768
[TBL] [Abstract][Full Text] [Related]
16. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
17. Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.
Devillier R; Fürst S; El-Cheikh J; Castagna L; Harbi S; Granata A; Crocchiolo R; Oudin C; Mohty B; Bouabdallah R; Chabannon C; Stoppa AM; Charbonnier A; Broussais-Guillaumot F; Calmels B; Lemarie C; Rey J; Vey N; Blaise D
Biol Blood Marrow Transplant; 2014 Mar; 20(3):370-4. PubMed ID: 24315846
[TBL] [Abstract][Full Text] [Related]
18. Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin.
Yu ZP; Ding JH; Wu F; Liu J; Wang J; Cheng J; Zhao G
Biol Blood Marrow Transplant; 2012 Apr; 18(4):593-9. PubMed ID: 21846461
[TBL] [Abstract][Full Text] [Related]
19. Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.
Kröger N; Solano C; Wolschke C; Bandini G; Patriarca F; Pini M; Nagler A; Selleri C; Risitano A; Messina G; Bethge W; Pérez de Oteiza J; Duarte R; Carella AM; Cimminiello M; Guidi S; Finke J; Mordini N; Ferra C; Sierra J; Russo D; Petrini M; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Bonifazi F
N Engl J Med; 2016 Jan; 374(1):43-53. PubMed ID: 26735993
[TBL] [Abstract][Full Text] [Related]
20. Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
Nakai K; Mineishi S; Kami M; Saito T; Hori A; Kojima R; Imataki O; Hamaki T; Yoshihara S; Ohnishi M; Kim SW; Ando T; Fumitoh A; Kanda Y; Makimoto A; Tanosaki R; Kanai S; Heike Y; Ohnishi T; Kawano Y; Wakasugi H; Takaue Y
Transplantation; 2003 Jun; 75(12):2135-43. PubMed ID: 12829926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
